Global Biodefense Market Size Study & Forecast, By Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Others), and Regional Analysis, 2023-2030

Description

List of Tables

Global Biodefense Market is valued approximately at USD 15.2 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.0% over the forecast period 2023-2030. Biodefense is generally described as those strategies, measures, and actions that are conducted to protect against biological threats such as the deliberate utilization of biological agents as weapons and naturally occurring outbreaks of infectious diseases. These measures are conducted in response to the need to reestablish a nation's biosecurity defenses against infectious diseases or biological poisons. The biodefense is used in biological warfare with the intention of killing or infecting people, animals, or the environment. Living organisms are typically used as biological agents in bioterrorism. These generally include bacteria, viruses, fungi, or toxins that are utilized on purpose to infect and kill people, wreaking havoc on society and the economy. The growing investment from private players, increasing threat of biological agents, rising focus on public health preparedness, rising emphasis on early detection and response and surging use of drones and robots in biodefense are the key factors that are attributing to the market demand around the world.

Furthermore, governments are substantially funding vaccine research and development to prepare for any bioterrorism strikes. As a result of government initiatives to be prepared for any form of bioterrorism, pharmaceutical businesses working in the biodefense sector have enormous chances to grow. In October 2022, the Government of America has developed a new defense strategy against pandemic and other biological threats. A revamped National Biodefense Strategy was anticipated to offer precise instructions on how the US government ought to react to potential health dangers in June 2022. Also, Emergent Bioscience reported an increase of USD 48.6 million in Q1 2022 Anthrax vaccine revenue over Q1 2021. The timing of delivery to the United States government (USG), specifically the Strategic National Stockpile (SNS), is a major factor in the growth. Additionally, the business got an AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) contract amendment in September 2021 for an estimated USD 399 million to supply more AV7909 doses through March 2023. Thereby, rising government focus and funding towards biodefense strategies are exhibiting a positive influence on the market growth. Moreover, the rapid technological advancement, as well as the growing research and development activities present various lucrative opportunities for the market growth over the forecast years. However, the Low market penetration in developing and underdeveloped countries and the limited funding and budget constraints are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Biodefense Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the growing awareness among the population, the presence of high federal funding, along with increasing technological advancements. Whereas, Asia Pacific is expected to account as fastest growing region over the forecast years. The surging investments in R&D, the rising threat of harmful biological materials, as well as well-established vaccine production facilities in the region are significantly propelling the market demand across the region.

Major market players included in this report are:

XOMA corporation
Altimmune Inc.
Emergent Biosolutions Inc.
Dynavax Technologies Corporation.
SIGA Technologies.
Elusys Therapeutics Inc.
Ichor Medical Systems.
Dynport Vaccine Company.
Cleveland Biolabs.
Bavarian Nordic.

Recent Developments in the Market:

In May 2022, Emergent BioSolutions Inc. announced that it had signed a legal agreement with Chimerix, Inc. to acquire all Chimerix's exclusive worldwide rights to the antiviral drug TEMBEXA (brincidofovir), which the FDA first approved for use in treating smallpox in people of all ages.
In June 2022, Emergent BioSolutions Inc. stated that the US Food and Drug Administration (FDA) had accepted the Biologics Licence Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) for review.

Global Biodefense Market Report Scope:

Historical Data: 2020 - 2021
Base Year for Estimation: 2022
Forecast period: 2023-2030
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Biodefense Market, by region, 2020-2030 (USD Billion)
- 1.2.2. Biodefense Market, by Product, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Biodefense Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Biodefense Market Dynamics

3.1. Biodefense Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing threat of biological agents
  - 3.1.1.2. Rising government focus and funding towards biodefense strategies
- 3.1.2. Market Challenges
  - 3.1.2.1. Limited funding and budget constraints
  - 3.1.2.2. Low market penetration in developing and underdeveloped countries
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rapid technological advancements
  - 3.1.3.2. Growing research and development activities

Chapter 4. Global Biodefense Market: Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economic
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Biodefense Market, by Product

5.1. Market Snapshot
5.2. Global Biodefense Market by Product, Performance - Potential Analysis
5.3. Global Biodefense Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Biodefense Market, Sub Segment Analysis
- 5.4.1. Anthrax
- 5.4.2. Smallpox
- 5.4.3. Botulism
- 5.4.4. Radiation/Nuclear
- 5.4.5. Others

Chapter 6. Global Biodefense Market, Regional Analysis

6.1. Top Leading Countries
6.2. Top Emerging Countries
6.3. Biodefense Market, Regional Market Snapshot
6.4. North America Biodefense Market
- 6.4.1. U.S. Biodefense Market
  - 6.4.1.1. Product breakdown estimates & forecasts, 2020-2030
- 6.4.2. Canada Biodefense Market
6.5. Europe Biodefense Market Snapshot
- 6.5.1. U.K. Biodefense Market
- 6.5.2. Germany Biodefense Market
- 6.5.3. France Biodefense Market
- 6.5.4. Spain Biodefense Market
- 6.5.5. Italy Biodefense Market
- 6.5.6. Rest of Europe Biodefense Market
6.6. Asia-Pacific Biodefense Market Snapshot
- 6.6.1. China Biodefense Market
- 6.6.2. India Biodefense Market
- 6.6.3. Japan Biodefense Market
- 6.6.4. Australia Biodefense Market
- 6.6.5. South Korea Biodefense Market
- 6.6.6. Rest of Asia Pacific Biodefense Market
6.7. Latin America Biodefense Market Snapshot
- 6.7.1. Brazil Biodefense Market
- 6.7.2. Mexico Biodefense Market
6.8. Middle East & Africa Biodefense Market
- 6.8.1. Saudi Arabia Biodefense Market
- 6.8.2. South Africa Biodefense Market
- 6.8.3. Rest of Middle East & Africa Biodefense Market

Chapter 7. Competitive Intelligence

7.1. Key Company SWOT Analysis
- 7.1.1. Company 1
- 7.1.2. Company 2
- 7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
- 7.3.1. XOMA corporation
  - 7.3.1.1. Key Information
  - 7.3.1.2. Overview
  - 7.3.1.3. Financial (Subject to Data Availability)
  - 7.3.1.4. Product Summary
  - 7.3.1.5. Recent Developments
- 7.3.2. Altimmune Inc.
- 7.3.3. Emergent Biosolutions Inc.
- 7.3.4. Dynavax Technologies Corporation.
- 7.3.5. SIGA Technologies.
- 7.3.6. Elusys Therapeutics Inc.
- 7.3.7. Ichor Medical Systems.
- 7.3.8. Dynport Vaccine Company.
- 7.3.9. Cleveland Biolabs.
- 7.3.10. Bavarian Nordic.

Chapter 8. Research Process

8.1. Research Process
- 8.1.1. Data Mining
- 8.1.2. Analysis
- 8.1.3. Market Estimation
- 8.1.4. Validation
- 8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Biodefense Market, report scope
TABLE 2. Global Biodefense Market estimates & forecasts by region 2020-2030 (USD Billion)
TABLE 3. Global Biodefense Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Biodefense Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 5. Global Biodefense Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Biodefense Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Biodefense Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Biodefense Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Biodefense Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Biodefense Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Biodefense Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Biodefense Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Biodefense Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. U.S. Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 16. U.S. Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. Canada Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. Canada Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. UK Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. UK Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. Germany Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. Germany Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. France Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. France Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. Italy Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. Italy Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Spain Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Spain Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. RoE Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. RoE Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. China Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. China Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. India Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. India Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. Japan Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. Japan Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. South Korea Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. South Korea Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. Australia Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. Australia Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. RoAPAC Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. RoAPAC Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. Brazil Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. Brazil Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Mexico Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Mexico Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. RoLA Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. RoLA Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. Saudi Arabia Biodefense Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. South Africa Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoMEA Biodefense Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Biodefense Market
TABLE 69. List of primary sources, used in the study of global Biodefense Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Biodefense Market, research methodology
FIG 2. Global Biodefense Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Biodefense Market, key trends 2022
FIG 5. Global Biodefense Market, growth prospects 2023-2030
FIG 6. Global Biodefense Market, porters 5 force model
FIG 7. Global Biodefense Market, pest analysis
FIG 8. Global Biodefense Market, value chain analysis
FIG 9. Global Biodefense Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Biodefense Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Biodefense Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Biodefense Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Biodefense Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Biodefense Market, regional snapshot 2020 & 2030
FIG 15. North America Biodefense Market 2020 & 2030 (USD Billion)
FIG 16. Europe Biodefense Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Biodefense Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Biodefense Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Biodefense Market 2020 & 2030 (USD Billion)